Market Overview:
Epigenetics is the study of how your behaviors and environment can cause changes that affect the way the genes work. Through epigenetic modifications, specific long-term phenotypic consequences can arise from environmental influence on slowly evolving genomic DNA. Several lifestyle factors may lead to change in epigenetic patterns, such as diet, obesity, physical activity, tobacco smoking, and alcohol consumption.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1772
Competitive Landscape:
Major players operating in the global epigenetics market include, Bio-Rad Laboratories, Inc., Diagenode s. a., Enzo Life Sciences, Inc., Illumina Inc., Merck Millipore Limited, New England Biolabs Inc., Qiagen Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.
Key Market Drivers:
R&D in epigenetic drugs is expected to propel growth of the global epigenetics market over the forecast period. For instance, the study, ‘Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy’, published in May 2020, in Annals of Clinical and Translational Neurology, reported that treatment with certain epigenetic medicines may help compensate for a deficiency in the ABCD1 gene in patients with adrenoleukodystrophy.
Covid-19 Impact Analysis
Globally, as of 6:21pm CET, 26 November 2021, there have been 259,502,031 confirmed cases of COVID-19, including 5,183,003 deaths, reported to WHO. As of 24 November 2021, a total of 7,702,859,718 vaccine doses have been administered. Epigenetic research might help to develop effective strategies for COVID-19 treatment.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1772
Key Takeaways
Major players operating in the global epigenetics market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2020, Epizyme, Inc the U.S. Food and Drug Administration granted accelerated approval to tazemetostat (TAZVERIK, Epizyme, Inc.) for adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
Major players operating in the global epigenetics market are also focused on adopting partnership strategies to enhance their market share. For instance, in April 2021, Zenith Epigenetics Ltd. entered into an agreement with Astellas Pharma Inc. to evaluate ZEN-3694, Zenith’s BET inhibitor, in combination with Astellas and Pfizer’s androgen receptor inhibitor, XTANDI (enzalutamide), in patients with metastatic castration resistant prostate cancer.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1772
Table of Content
Global Epigenetics Market Research Report
Section 1: Global Epigenetics Industry Overview
Section 2: Global Economic Impact on Epigenetics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Epigenetics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Epigenetics Market Forecast
Other Reports
Plant Phenotyping Market –
Fungal Otitis Externa Market –
Anti-epileptic Drugs Market –
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837